AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|AAPL288.37+6.63 (+2.35%) ▲|ABBV251.95-2.37 (-0.93%) ▼|ABT91.04-1.68 (-1.81%) ▼|ACN123.78-0.96 (-0.77%) ▼|ADBE202.94-3.49 (-1.69%) ▼|AMAT734.71+40.07 (+5.77%) ▲|AMD579.42+39.93 (+7.40%) ▲|AMGN361.56+1.01 (+0.28%) ▲|AMT165.18-3.49 (-2.07%) ▼|AMZN238.75-1.39 (-0.58%) ▼|AVGO375.45+3.00 (+0.80%) ▲|AXP337.67-3.22 (-0.94%) ▼|BA216.21+1.52 (+0.71%) ▲|BAC57.25-0.64 (-1.10%) ▼|BKNG179.08-3.33 (-1.83%) ▼|BLK960.13+9.96 (+1.05%) ▲|BMY57.93-0.63 (-1.08%) ▼|BNY145.06+1.26 (+0.88%) ▲|BRK-B497.96+1.96 (+0.39%) ▲|C140.62-1.87 (-1.31%) ▼|CAT1,069.75+36.56 (+3.54%) ▲|CL91.86-0.54 (-0.58%) ▼|CMCSA24.37+0.15 (+0.60%) ▲|COF201.15-1.13 (-0.56%) ▼|COP104.12-0.08 (-0.08%) ▼|COST936.84-9.84 (-1.04%) ▼|CRM156.03-1.90 (-1.20%) ▼|CSCO117.28-0.42 (-0.36%) ▼|CVS103.93+0.35 (+0.34%) ▲|CVX167.01-1.46 (-0.87%) ▼|DE634.41+9.40 (+1.50%) ▲|DHR190.84-1.94 (-1.01%) ▼|DIS96.57-1.31 (-1.34%) ▼|DUK127.68-0.65 (-0.51%) ▼|EMR143.72+0.90 (+0.63%) ▲|FDX311.12-14.28 (-4.39%) ▼|GD352.88+4.81 (+1.38%) ▲|GE368.93-4.78 (-1.28%) ▼|GEV1,162.31+59.80 (+5.42%) ▲|GILD126.05-0.28 (-0.22%) ▼|GM76.57-0.78 (-1.00%) ▼|GOOG353.14+1.86 (+0.53%) ▲|GOOGL356.18+2.53 (+0.72%) ▲|GS1,013.39-6.83 (-0.67%) ▼|HD352.23+1.42 (+0.40%) ▲|HON224.07-3.73 (-1.64%) ▼|IBM280.39+2.39 (+0.86%) ▲|INTC141.86+10.14 (+7.70%) ▲|INTU261.90-4.51 (-1.69%) ▼|ISRG400.45-5.52 (-1.36%) ▼|JNJ256.31-2.20 (-0.85%) ▼|JPM328.81-0.58 (-0.18%) ▼|KO81.90-0.76 (-0.91%) ▼|LIN521.58+10.52 (+2.06%) ▲|LLY1,210.15-19.78 (-1.61%) ▼|LMT505.37+3.30 (+0.66%) ▲|LOW219.70+0.05 (+0.02%) ▲|LRCX434.39+23.48 (+5.71%) ▲|MA511.82+2.18 (+0.43%) ▲|MCD270.52+3.34 (+1.25%) ▲|MDLZ58.51-1.65 (-2.73%) ▼|MDT78.82-2.11 (-2.61%) ▼|META560.14-2.46 (-0.44%) ▼|MMM161.47-0.97 (-0.59%) ▼|MO72.75-1.30 (-1.75%) ▼|MRK128.34-1.04 (-0.80%) ▼|MS209.36-2.36 (-1.11%) ▼|MSFT371.16+2.59 (+0.70%) ▲|MU1,154.96+9.68 (+0.85%) ▲|NEE88.24-0.43 (-0.48%) ▼|NFLX72.44-1.35 (-1.82%) ▼|NKE41.53+0.05 (+0.12%) ▲|NOW97.50-2.47 (-2.47%) ▼|NVDA198.24+3.27 (+1.68%) ▲|ORCL146.39-1.38 (-0.93%) ▼|PEP136.73-1.95 (-1.41%) ▼|PFE24.14-0.23 (-0.94%) ▼|PG146.45-2.00 (-1.35%) ▼|PLTR117.94+2.24 (+1.94%) ▲|PM181.01-1.86 (-1.01%) ▼|QCOM185.97-2.75 (-1.46%) ▼|RTX187.92+0.59 (+0.32%) ▲|SBUX103.01-1.05 (-1.01%) ▼|SCHW92.35+1.80 (+1.99%) ▲|SO96.46-0.29 (-0.30%) ▼|SPG224.76-2.81 (-1.23%) ▼|T20.76-1.07 (-4.88%) ▼|TMO502.51-3.91 (-0.77%) ▼|TMUS168.35-5.62 (-3.23%) ▼|TSLA416.90+5.06 (+1.23%) ▲|TXN297.42+11.94 (+4.18%) ▲|UBER72.82-2.68 (-3.55%) ▼|UNH416.40-3.42 (-0.81%) ▼|UNP272.73+0.03 (+0.01%) ▲|UPS107.42-0.60 (-0.55%) ▼|USB60.73-0.03 (-0.05%) ▼|V342.83+1.18 (+0.35%) ▲|VZ42.62-1.49 (-3.37%) ▼|WFC82.82-0.69 (-0.83%) ▼|WMT113.55-1.05 (-0.92%) ▼|XOM136.31+0.25 (+0.18%) ▲|
32 C
New York
Tuesday, June 30, 2026

Tag: release

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRAL

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”), of the important August 4, 2026 lead plaintiff deadline.

Lundin Mining Capital Markets Day Highlights Strategic Vision for Leading Growth and Shareholder Returns

VANCOUVER, BC, June 16, 2026 /CNW/ - (TSX: LUN) (Nasdaq Stockholm: LUMI) Lundin Mining Corporation ("Lundin Mining" or the "Company") will host a Capital Markets...

Baozun Announces Results of Annual General Meeting of Shareholders

SHANGHAI, June 17, 2026 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution...

FULL CIRCLE BOYS DROP HIGH-ENERGY SPORTS ANTHEM “BLEACHERS” WITH EXPLOSIVE MUSIC VIDEO AND VIRAL DANCE CHALLENGE

The latest single from Full Circle Boys arrives with Keone Madrid-choreographed visuals and a towel-waving dance challenge built for stadiums, arenas, and living rooms everywhere.LOS...

GFiber and Quext Bring First-of-its-Kind Multifamily Network Experience to Irvine Company’s Pacifica Place

GFiber and Quext debut a first-of-its-kind Wi-Fi 7 and smart home network experience at Irvine Company’s Pacifica Place apartments.

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 30, 2025 and April 30, 2026, inclusive (the “Class Period”), of the important August 7, 2026 lead plaintiff deadline.

[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends,...

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.

Five Star Bank Earns #1 Ranking in San Francisco Business Times’ Best Places to Work

The community bank earned the highest ranking in Quantum Workplace employee-voted survey
The community bank earned the highest ranking in Quantum Workplace  employee-voted survey

Micropolis Robotics Expands Physical AI Portfolio with Five-Year Autonomous Sweeper Deployment Agreement with Abu Dhabi Government

Long-term agreement with the Department of Municipalities and Transport advances the deployment of Physical AI and autonomous municipal services across Abu Dhabi
Long-term agreement with the Department of Municipalities and Transport advances the deployment of Physical AI and autonomous municipal services across Abu Dhabi

Brookfield Global Infrastructure Securities Income Fund Announces Quarterly Distribution

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Brookfield Global Infrastructure Securities Income Fund (the “Fund”) (TSX: BGI.UN) today announced a distribution of C$0.15 per unit for the quarter ending June 30, 2026. The distribution will be paid on or before July 15, 2026 to holders of record on June 30, 2026.

Nova Klúbburinn hf.: Viðskipti stjórnanda

Sjá meðfylgjandi tilkynningu.

SURGE ENERGY INC. ANNOUNCES APPROVAL FOR RENEWAL OF NORMAL COURSE ISSUER BID

CALGARY, AB, June 16, 2026 /CNW/ - Surge Energy Inc. ("Surge" or the "Company") (TSX: SGY) is pleased to announce that the Toronto Stock Exchange...

Azitra, Inc. to Present at 2026 BIO International Convention

BRANFORD, Conn., June 16, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRelease